211 related articles for article (PubMed ID: 1301849)
1. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
Zhao XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
[TBL] [Abstract][Full Text] [Related]
2. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
Sibbitt WL; Mathews PM; Bankhurst AD
J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha regulation of lymphocyte function in systemic lupus erythematosus.
Sibbitt WL; Froelich CJ; Bankhurst AD
Clin Immunol Immunopathol; 1984 Jul; 32(1):70-80. PubMed ID: 6733982
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
Neighbour PA; Grayzel AI; Miller AE
Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
[TBL] [Abstract][Full Text] [Related]
8. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
[TBL] [Abstract][Full Text] [Related]
9. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus.
Gaspar ML; Alvarez-Mon M; Gutiérrez C
Clin Immunol Immunopathol; 1988 Nov; 49(2):204-14. PubMed ID: 3139345
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?
Riccieri V; Spadaro A; Parisi G; Taccari E; Moretti T; Bernardini G; Favaroni M; Strom R
Lupus; 2000; 9(5):333-7. PubMed ID: 10878724
[TBL] [Abstract][Full Text] [Related]
13. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
14. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients.
Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362
[TBL] [Abstract][Full Text] [Related]
16. Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.
Brookes RH; Kew MC; Rabson AR
Cancer Immunol Immunother; 1987; 25(2):149-52. PubMed ID: 2822243
[TBL] [Abstract][Full Text] [Related]
17. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
Kozlowski SH; Hirsen DJ; Jackson EJ
J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
[TBL] [Abstract][Full Text] [Related]
18. Thymostimulin increases natural cytotoxic activity in patients with breast cancer.
Meneses G; Delgado MA; Perez-Machado MA; Prieto A; Alonso R; Carrion F; Lanzos E; Alvarez-Mon M
Int J Immunopharmacol; 1997 Apr; 19(4):187-93. PubMed ID: 9373769
[TBL] [Abstract][Full Text] [Related]
19. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.
Sibbitt WL; Froelich CJ; Bankhurst AD
Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808
[TBL] [Abstract][Full Text] [Related]
20. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
